• Home
  •  / FoRx Therapeutics

FoRx Therapeutics

  • Total Funding$10.8 M

OverviewSuggest Edit

FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer. The company focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.
TypePrivate
Founded2019
HQBasel, CHMap
Websiteforxtherapeutics.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Jun 2022)18(+6%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at FoRx Therapeutics

Florian Muellershausen

Florian Muellershausen

Board Member
Tarig Bashir

Tarig Bashir

CEO
Vincent Ossipow

Vincent Ossipow

Board Member
Vincent Brichard

Vincent Brichard

Board Member
Denis Patrick

Denis Patrick

Board Member
Show more

FoRx Therapeutics Office Locations

FoRx Therapeutics has an office in Basel
Basel, CH (HQ)
210, Lichtstrasse 35
Show all (1)

FoRx Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2019

FoRx Therapeutics total Funding

$10.8 m

FoRx Therapeutics latest funding size

$10.84 m

Time since last funding

2 years ago

FoRx Therapeutics investors

Novartis Venture Fund, Pfizer Venture Investments, Life Sciences Partners, Omega Funds, Pfizer, M Ventures
FoRx Therapeutics's latest funding round in April 2020 was reported to be $10.8 m. In total, FoRx Therapeutics has raised $10.8 m
Show all financial metrics

FoRx Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

Learn more about our premium products
SecurityScorecard logo

FoRx Therapeutics Online and Social Media Presence

FoRx Therapeutics's Trends

Embed Graph

FoRx Therapeutics News and Updates

April 22, 2020

FoRx Therapeutics Closes €10M Seed Financing Round

FoRx Therapeutics, a Basel, Switzerland-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways, closed a EUR 10m seed financing round.

 FoRx Therapeutics Frequently Asked Questions

  • When was FoRx Therapeutics founded?

    FoRx Therapeutics was founded in 2019.

  • Who are FoRx Therapeutics key executives?

    FoRx Therapeutics's key executives are Florian Muellershausen, Tarig Bashir and Vincent Ossipow.

  • How many employees does FoRx Therapeutics have?

    FoRx Therapeutics has 18 employees.

  • Who are FoRx Therapeutics competitors?

    Competitors of FoRx Therapeutics include Intrepida Bio, Ionova Life Science and ADC Therapeutics.

  • Where is FoRx Therapeutics headquarters?

    FoRx Therapeutics headquarters is located at 210, Lichtstrasse 35, Basel.

  • Where are FoRx Therapeutics offices?

    FoRx Therapeutics has an office in Basel.

  • How many offices does FoRx Therapeutics have?

    FoRx Therapeutics has 1 office.